Corbus Pharmaceutical Holdings, Inc. (CRBP)

[glenn1919]

CRBP..........https://finviz.com/quote.ashx?t=CRBP&ty=c&ta=1&p=d

[glenn1919]

CRBP........................https://www.tradingview.com/x/af5HLESa/

[glenn1919]

CRBP.....................................https://stockcharts.com/h-sc/ui?s=CRBP&p=W&b=5&g=0&id=p86431144783

[The Night Stalker]

strong

[glenn1919]

CRBP.................................http://shortvolumes.com/?t=crbp

[The Night Stalker]

on .20 break

[glenn1919]

CRBP................................https://stockcharts.com/h-sc/ui?s=CRBP

[RNsidersbuying]

A secondary, obviously, yes

[subslover]

Yes of course I did. What's next? LOL

[TheFinalCD]

did you miss this today also?

[Ricorich]

This site used to be very popular, not anymore.
I remember 20 years ago was different, we all moved to other apps and platforms.

[interloper]

Yeah, I have been seeing this lately. Stocks, running, and no one’s on iHub.

[DollarDan]

This stock is up nearly 70% today and no one is chatting about it here? I guess this shows the popularity of this site.

[Newc]

What’s going on? I like the accumulation off 52 low weekly rsi.

Nice volume too.

[subslover]

Thank you DollarDan.

[DollarDan]

BioSpace put out this story yesterday. Maybe it is the reason.

https://www.biospace.com/article/beyond-anti-pd-1-pd-li-3-companies-swing-for-the-fences-with-new-targets-/?keywords=corbus

[subslover]

Volume pouring in on NO NEWS!

[subslover]

https://www.otcmarkets.com/filing/html?id=16131925&guid=vsR-k6atwjFYXih

[dfrank1988]

Corbus Pharmaceuticals Second Quarter 2022 Financial Results

[DollarDan]

Anyone home here?

[ernie44]

NOPE---------Just us chickens

oh ya and reindeer

[BuyLow_Sell_High]

Are there any catalysts here?

[ernie44]

will leave this buying to Doctors---they can afford to lose

so far-am 0 for 3

[tigertiger88]

looking better today

[tigertiger88]

Picked up this am, wow lots of bargains today

[CreampieMafia]

This is gona gap up to 7 ez. Im surprised there isnt alot of chatter about this stock in this forum

[ClayTrader]

* * $CRBP Video Chart 02-10-2021 * *

Link to Video - click here to watch the technical chart video

[wesley_]

$2.95 so far... nice

[fitzkarz]

Over reaction to some not so great new.
Rich getting richer, Go $CRBP!

[Stoquer1]

This will be a big squeeze play I loaded up sub 2.00. With yesterdays volume and gaps at 6.00ish and 9.00ish we got lots of room to run INO

[stockticks]

Bad test results.

[Laszlo1]

Somebody please can tell me why is this dropped in last year in select ember from 10$?

[ClayTrader]

* * $CRBP Video Chart 02-02-2021 * *

Link to Video - click here to watch the technical chart video

[NMBR1]

ROCE Insights For Corbus Pharmaceuticals

2/2/21, 10:44 AM
February 2, 2021 10:44 AM ET (BZ Newswire) -- Earnings

During Q3, Corbus Pharmaceuticals (NASDAQ:CRBP) brought in sales totaling $1.23 million. However, earnings decreased 10.92%, resulting in a loss of $33.97 million. Corbus Pharmaceuticals collected $286.35 thousand in revenue during Q2, but reported earnings showed a $38.14 million loss.

Why ROCE Is Significant

Changes in earnings and sales indicate shifts in Corbus Pharmaceuticals's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Corbus Pharmaceuticals posted an ROCE of -1.16%.

It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.

ROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows Corbus Pharmaceuticals is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.

In Corbus Pharmaceuticals's case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.

Q3 Earnings Insight

Corbus Pharmaceuticals reported Q3 earnings per share at $-0.43/share, which did not meet analyst predictions of $-0.42/share.

Copyright © 2021 Benzinga (BZ Newswire, http://www.benzinga.com/licensing). Benzinga does not provide investmentadvice. All rights reserved. Write to [e-mail] with any questions about this content. Subscribe to Benzinga Pro (http://pro.benzinga.com).

[stockticks]

Nice turn big volume coming in.

[Bpink]

The Financials look like shit

[ernie44]

trying to make a comeback----typical farm team

[shurtha2000]

In $2.28

[Skeptical]

don't pay to much attntion to pre-market. It,s easier to manipulate. I like to see they make it pullback and clean the market

[dinogreeves]

It looks horrible right now, what gives? Offering was at $6, the only thing is shorts are piling on.

[maximumgriff]

By the trading, it looks not today lol

[dinogreeves]

I could be mistaken, but I read somewhere it is today sometime.

[maximumgriff]

When is vote?

[Skeptical]

pre-market announces a great day. We still don't know why the recent moves but we what we know, the stock is strong. The gap to $9 is still acrive

[dinogreeves]

Legalization tomorrow will move this into 6-8 tomorrow.

[ClayTrader]

* * $CRBP Video Chart 02-01-2021 * *

Link to Video - click here to watch the technical chart video

[Joecanada13]

Weeeeeeeee!!!

[eom7]

Looks like you may get your wish!

[ArtieB]

If this were to be targeted for a short squeeze, $9 easy.

[Joecanada13]

Yes